troglitazone has been researched along with pyruvic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, YS; Jung, KH; Lee, JH; Lee, KH; Moon, SH; Park, JW | 1 |
1 other study(ies) available for troglitazone and pyruvic acid
| Article | Year |
|---|---|
Troglitazone exerts metabolic and antitumor effects on T47D breast cancer cells by suppressing mitochondrial pyruvate availability.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyglucose; Dose-Response Relationship, Drug; Female; Glycolysis; Humans; Mitochondria; Pyruvic Acid; Ribosomal Protein S6 Kinases, 70-kDa; Troglitazone | 2020 |